Press release
Personalized Medicine Biomarkers Market to See Significant Growth as Healthcare Industry Shifts Towards Precision Medicine
Personalized Medicine Biomarkers Market
The Global Personalized Medicine Biomarkers Market is valued at US$ 22.9 Bn in 2023, and it is expected to reach US$ 59.1 Bn by 2031, with a CAGR of 12.8% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2924
The Personalized Medicine Biomarkers Market is experiencing significant growth, driven by the increasing demand for treatments tailored to the specific needs of individual patients. Personalized medicine biomarkers-such as genes, proteins, and metabolites-provide essential insights into a patient's health status and their potential response to targeted therapies. These biomarkers are critical for early disease detection, predicting treatment outcomes, and designing customized treatment plans that optimize efficacy while reducing adverse effects. In oncology, biomarkers like BRCA1/2 and EGFR are instrumental in selecting targeted therapies based on specific genetic mutations present in tumors.
Personalized medicine biomarkers are employed across various stages of disease management, including diagnosis, prognosis, treatment selection, and monitoring. Genomic biomarkers help identify DNA mutations that increase the risk of certain diseases, while proteomic and metabolic biomarkers offer valuable information about disease presence and progression. The rising global prevalence of chronic conditions such as cancer and cardiovascular diseases is driving the demand for precise, personalized diagnostic and therapeutic solutions. Regulatory support from agencies such as the FDA, through initiatives promoting biomarker research and expediting the approval process for new therapies, is fostering market growth, improving patient outcomes, and advancing the field of precision medicine.
List of Prominent Players in the Personalized Medicine Biomarkers Market:
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Foundation Medicine, Inc.
• Genomic Health, Inc
• Guardant Health, Inc.
• Illumina, Inc.
• Luminex Corporation
• Merck KGaA
• Myriad Genetics, Inc
• QIAGEN N.V
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Coriell Life Sciences.
• Laboratory Corporation of America Holding
• NeoGenomics Laboratories
• Quest Diagnostics Incorporated
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Market Dynamics:
Drivers:
The Personalized Medicine Biomarkers Market is experiencing rapid growth, primarily driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which necessitate tailored treatment solutions. In 2022, a global total of 19,976,499 cancer cases were diagnosed, with an age-standardized incidence rate of 196.9 per 100,000, highlighting the urgent need for personalized approaches to healthcare. Biomarkers, which serve as biological indicators of disease mechanisms and treatment responses, are crucial in enhancing diagnostic accuracy and improving patient outcomes. In oncology, biomarkers are particularly valuable for identifying genetic mutations and tumor-specific characteristics, allowing for the selection of targeted therapies that are customized to individual patients. This approach not only increases treatment efficacy but also minimizes side effects, making it increasingly preferred in modern medicine. Furthermore, advancements in genomics, proteomics, and bioinformatics are accelerating the discovery and validation of biomarkers, attracting substantial investments from pharmaceutical companies and research institutions.
Challenges:
The market for personalized medicine biomarkers faces several emerging challenges, including high discovery costs, complex regulatory requirements, ethical considerations, limited awareness among service providers and patients, and issues related to reimbursement. These challenges present significant barriers to both the adoption and accessibility of personalized biomarker-based solutions.
Regional Trends:
North America, particularly the United States, represents a dominant market for Personalized Medicine Biomarkers, supported by a well-established healthcare infrastructure, leading biotechnology firms, and government initiatives such as the 21st Century Cures Act, which streamlines the approval processes for new treatments. The rising incidence of chronic conditions such as cancer and cardiovascular diseases further drives the demand for personalized treatments. Additionally, the adoption of advanced sequencing technologies and favorable reimbursement policies are key factors propelling the market growth in this region.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2924
Recent Developments:
• In June 2024, Guardant Health, Inc. launched an enhanced version of its Guardant360 TissueNext test, expanding its gene panel to 498 cancer biomarkers. This update helps oncologists better identify effective targeted therapies for advanced cancer patients. The improved test also features a streamlined workflow for faster results.
• In April 2024, Bio-Rad Laboratories, Inc. has launched its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. This addition expands the company's Droplet Digital PCR (ddPCRTM) offerings, enhancing mutation detection for oncology research, therapy selection, and disease monitoring.
Segmentation of Personalized Medicine Biomarkers Market-
By Type:
• Genetic Biomarkers
• Protein Biomarkers
• Metabolite Biomarkers
By Application:
• Oncology
• Neurology
• Diabetes
• Autoimmune Diseases
• Cardiology
• Others
By End User:
• Hospitals
• Diagnostic Laboratories
• Research Institutions
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/personalized-medicine-biomarkers-market/2924
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Personalized Medicine Biomarkers Market to See Significant Growth as Healthcare Industry Shifts Towards Precision Medicine here
News-ID: 4000640 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Biomarkers
Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032.
Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024
This latest report researches the industry structure, sales, revenue,…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…
